Kentaro Inui

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 359 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Increased thickness of the arterial intima‐media detected by ultrasonography in patients with rheumatoid arthritis

Yasuro Kumeda, Masaaki Inaba, Hitoshi Goto et al. · Arthritis & Rheumatism · 2002 · 314 citations

Medicine, Clinical Sciences, Internal Medicine +17

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler et al. · The Lancet · 2019 · 214 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Low-intensity pulsed ultrasound accelerates bone maturation in distraction osteogenesis in rabbits

Akitoshi Shimazaki, Kentaro Inui, Yoshiaki Azuma et al. · Journal of Bone and Joint Surgery - British Volume · 2000 · 154 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis

Mayumi Nagata-Sakurai, Masaaki Inaba, Hitoshi Goto et al. · Arthritis & Rheumatism · 2003 · 100 citations

Medicine, Clinical Sciences, Internal Medicine +17